Inventaire - 友達とコミュニティはあなたのベストな図書館です

Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial

著者

Jinani Jayasekera

Eric J Feuer

Angela Mariotto

Jeanne S Mandelblatt

この作品が含まれる作品: Journal of the National Cancer Institute

出版日: 2020-02-01

Cites articles 28

Date

タイトル

著者

2018-10-10

The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations

Laura Panattoni, Jinani Jayasekera, Jeanne S Mandelblatt
2018-12-01

Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer

Jinani Jayasekera, Yisheng Li, Eric J Feuer, Jeanne S Mandelblatt
2018-06-03

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph Sparano, Soonmyung Paik, E Claire Dees, George Sledge, Matthew P Goetz
2018-04-01

Medical Care Costs Associated With Cancer in Integrated Delivery Systems

K R Yabroff, Mark C Hornbrook
2018-03-28

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

Kathleen A. Cronin, Allison W Kurian
2018-01-08

Cost Effectiveness of Gene Expression Profile Testing in Community Practice

Jinani Jayasekera, Claudine Isaacs
2017-01-01

The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community

Ethan Basch
2017-02-21

Oncologist and organizational factors associated with variation in breast cancer multigene testing

Tracy A Lieu, Laurel A Habel, Jeanne S Mandelblatt
2016-06-08

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study

デニス・ディーペン, Sally L Glaser, Ann G Schwartz, Brenda Y Hernandez, Kathleen A. Cronin
2016-12-21

Recurrence risk perception and quality of life following treatment of breast cancer

Monica Morrow, Steven J Katz, Ann S Hamilton, Sarah T Hawley, Reshma Jagsi
2016-10-24

Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer

デニス・ディーペン, Ann S Hamilton, Steven J Katz, Allison W Kurian
2016-05-01

Breast cancer multigene testing trends and impact on chemotherapy use.

Tracy A Lieu
2016-02-08

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Fabrice André, Robert C. Bast, Ana Maria Gonzalez-Angulo, Minetta C Liu
2015-11-19

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Soonmyung Paik, E Claire Dees, エディス・A・ペレス, George Sledge, Joseph Sparano
2015-08-20

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

Claudine Isaacs
2014-03-15

Comparison of SEER Treatment Data With Medicare Claims

デニス・ディーペン, Jennifer L Lund, Kathleen A. Cronin, Angela Mariotto, Joan L. Warren
2012-07-30

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.

Claudine Isaacs
2011-10-20

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists

Judy Boughey
2011-01-12

Projections of the cost of cancer care in the United States: 2010-2020

K R Yabroff
2011-01-01

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

Foluso Ademuyiwa, Mangesh Thorat, George Sledge
2010-04-20

Communicating genetic and genomic information: health literacy and numeracy considerations

Deborah J. Bowen
2010-01-11

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
2008-04-29

Cost of care for elderly cancer patients in the United States

K R Yabroff
2007-01-10

Costs of cancer care: a view from the centers for Medicare and Medicaid services
2004-12-30

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Soonmyung Paik, Chungyeul Kim
2002-08-01

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

Carrie N Klabunde
1999-06-01

Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting
1995-12-01

Differences in initial treatment patterns and outcomes of lung cancer in the elderly

トマス・J・スミス

記事 - wd:Q92532687

Welcome to Inventaire

友達やコミュニティの図書館

もっと調べる